Ensysce Biosciences annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Ensysce Biosciences Depreciation & Amortization Growth & History (ENSC)
Ensysce Biosciences's depreciation and amortization was $6,533 for fiscal 2025.
View full Ensysce Biosciences company overviewEnsysce Biosciences annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $6,533 | $6,533 | — |
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | −$151 | — |
| 2021 | 2021-12-31 | $151 | −$50 | −24.88% |
| 2020 | 2020-12-31 | $201 | — | — |
Ensysce Biosciences quarterly depreciation and amortization
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6,533 | $6,533 | — |
| Q1 2026 | 2026-03-31 | $6,533 | $6,533 | — |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $0 | $0 | — |
| Q1 2025 | 2025-03-31 | $0 | $0 | — |
| Q3 2024 | 2024-09-30 | $0 | — | — |
| Q2 2024 | 2024-06-30 | $0 | — | — |
| Q1 2024 | 2024-03-31 | $0 | — | — |
| Q3 2021 | 2021-09-30 | $50 | $0 | 0.00% |
| Q2 2021 | 2021-06-30 | $50 | $0 | 0.00% |
| Q1 2021 | 2021-03-31 | $51 | — | — |
| Q3 2020 | 2020-09-30 | $50 | — | — |
| Q2 2020 | 2020-06-30 | $50 | — | — |
Ensysce Biosciences depreciation and amortization trends
Over the last five fiscal years, Ensysce Biosciences's depreciation and amortization increased from $201 to $6,533, a change of $6,332. The latest reported quarter, Q2 2026, shows $6,533.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ensysce Biosciences source filings ↗